Expression of 4-hydroxynonenal in esophageal squamous cell carcinoma

Zhang,Ying; Wang,Hu; Wu,Kezhou; Liu,Zhaoyong

doi:10.3892/ol.2017.6127

Expression of 4-hydroxynonenal in esophageal squamous cell carcinoma

Authors:
- Ying Zhang
- Hu Wang
- Kezhou Wu
- Zhaoyong Liu
View Affiliations

Affiliations: Department of Pathology, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China, Department of Orthopaedic Oncology, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China
Published online on: May 5, 2017 https://doi.org/10.3892/ol.2017.6127
Pages: 35-40
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common types of cancer in Asia, particular in China. However, the pathogenesis of ESCC has not previously been well demonstrated. A major product of lipid peroxidation, 4‑hydroxynonenal (4‑HNE), is considered to be an oxidative stress inducer, as it is involved in the pathogenesis of a number of degenerative diseases, including Alzheimer's disease, atherosclerosis, cataracts and cancer. In order to investigate the association between oxidative stress and the pathogenic process of ESCC, the present study determined the expression levels of 4‑HNE in 23 non‑malignant esophageal epithelial tissues, 11 esophageal carcinoma in situ tissues and 57 ESCC tissues from patients in the Chaoshan area, a high‑risk region for esophageal cancer in China. A significantly higher expression level of 4‑HNE was identified in ESCC tissues compared with that in non‑malignant esophageal epithelial tissues (P<0.05). Furthermore, immunohistochemical analysis demonstrated that expression levels of 4‑HNE were significantly associated with the clinical stage. The patients with positive staining of 4‑HNE revealed a poorer clinical outcome compared with that of patients with negative staining. 4‑HNE was significantly associated with the severity of inflammation and increased with the progression of precancerous lesions (P<0.05). These results provide pathological evidence that oxidative stress is a driving force of ESCC carcinogenesis.

View Figures

View References

1	Su M, Liu M, Tian DP, Li XY, Zhang GH, Yang HL, Fan X, Huang HH and Gao YX: Temporal trends of esophageal cancer during 1995–2004 in Nanao Island, an extremely high-risk area in China. Eur J Epidemiol. 22:43–48. 2007. View Article : Google Scholar : PubMed/NCBI
2	Napier KJ, Scheerer M and Misra S: Esophageal cancer: A review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
3	Tang WR, Chen ZJ, Lin K, Su M and Au WW: Development of esophageal cancer in Chaoshan region, China: Association with environmental, genetic and cultural factors. Int J Hyg Environ Health. 218:12–18. 2015. View Article : Google Scholar : PubMed/NCBI
4	Li K and Yu P: Food groups and risk of esophageal cancer in Chaoshan region of China: A high-risk area of esophageal cancer. Cancer Invest. 21:237–240. 2003. View Article : Google Scholar : PubMed/NCBI
5	Liu S, Huang B, Huang H, Li X, Chen G, Zhang G, Lin W, Guo D, Wang J, Yu Z, et al: Patrilineal background of esophageal cancer and gastric cardia cancer patients in a Chaoshan high-risk area in China. PLoS One. 8:e816702013. View Article : Google Scholar : PubMed/NCBI
6	Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
7	Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H and LLeonart ME: Oxidative stress and cancer: An overview. Ageing Res Rev. 12:376–390. 2013. View Article : Google Scholar : PubMed/NCBI
8	Georgakilas AG: Oxidative stress, DNA damage and repair in carcinogenesis: Have we established a connection? Cancer Lett. 327:3–4. 2012. View Article : Google Scholar : PubMed/NCBI
9	Shacter E and Weitzman SA: Chronic inflammation and cancer. Oncology (Williston Park). 16:217–226, 229; discussion 230–232. 2002.PubMed/NCBI
10	Rakoff-Nahoum S: Why cancer and inflammation? Yale J Biol Med. 79:123–130. 2006.PubMed/NCBI
11	Chen ZH and Niki E: 4-hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-HNE also exert protective effects? IUBMB Life. 58:372–373. 2006.PubMed/NCBI
12	Sehitogullar A, Aslan M, Sayr F, Kahraman A and Demir H: Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma. Redox Rep. 9:199–205. 2014. View Article : Google Scholar
13	Zhang Y, Zhang Y, Yun H, Lai R and Su M: Correlation of STAT1 with apoptosis and cell-cycle markers in esophageal squamous cell carcinoma. PLoS One. 9:e1139282014. View Article : Google Scholar : PubMed/NCBI
14	Islami F, Cao Y, Kamangar F, Nasrollahzadeh D, Marjani HA, Shakeri R, Fahimi S, Sotoudeh M, Dawsey SM, Abnet CC, et al: Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: A case-control study in a high-risk area and literature review. Eur J Cancer Prev. 22:461–466. 2013. View Article : Google Scholar : PubMed/NCBI
15	Hardbower DM, de Sablet T, Chaturvedi R and Wilson KT: Chronic inflammation and oxidative stress: The smoking gun for helicobacter pylori-induced gastric cancer? Gut Microbes. 4:475–481. 2013. View Article : Google Scholar : PubMed/NCBI
16	Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012. View Article : Google Scholar : PubMed/NCBI
17	Uttara B, Singh AV, Zamboni P and Mahajan RT: Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidanttherapeutic options. Curr Neuropharmacol. 7:65–74. 2009. View Article : Google Scholar : PubMed/NCBI
18	Dalleau S, Baradat M, Guéraud F and Huc L: Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 20:1615–1630. 2013. View Article : Google Scholar : PubMed/NCBI
19	Siegel SJ, Bieschke J, Powers ET and Kelly JW: The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry. 46:1503–1510. 2007. View Article : Google Scholar : PubMed/NCBI
20	Leonarduzzi G, Chiarpotto E, Biasi F and Poli G: 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res. 49:1044–1049. 2005. View Article : Google Scholar : PubMed/NCBI
21	Zhong H and Yin H: Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 4:193–199. 2015. View Article : Google Scholar : PubMed/NCBI
22	Mattson MP: Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, andassociated vascular and neurodegenerative disorders. Exp Gerontol. 44:625–633. 2009. View Article : Google Scholar : PubMed/NCBI
23	Samjoo IA, Safdar A, Hamadeh MJ, Raha S and Tarnopolsky MA: The effect of endurance exercise on both skeletal muscle and systemic oxidative stress in previously sedentary obese men. Nutr Diabetes. 3:e882013. View Article : Google Scholar : PubMed/NCBI